EPS for Accelerate Diagnostics, Inc. (AXDX) Expected At $-0.31; L & S Advisors Increased Pioneer Natural Resources (PXD) Position

April 22, 2018 - By Michael Collier

Analysts expect Accelerate Diagnostics, Inc. (NASDAQ:AXDX) to report $-0.31 EPS on May, 4.They anticipate $0.04 EPS change or 14.81% from last quarter’s $-0.27 EPS. After having $-0.27 EPS previously, Accelerate Diagnostics, Inc.’s analysts see 14.81% EPS growth. The stock increased 0.62% or $0.15 during the last trading session, reaching $24.5. About 135,175 shares traded. Accelerate Diagnostics, Inc. (NASDAQ:AXDX) has declined 0.88% since April 22, 2017 and is downtrending. It has underperformed by 12.43% the S&P500.

L & S Advisors Inc increased Pioneer Natural Resources (PXD) stake by 230.39% reported in 2017Q4 SEC filing. L & S Advisors Inc acquired 12,107 shares as Pioneer Natural Resources (PXD)’s stock rose 0.37%. The L & S Advisors Inc holds 17,362 shares with $3.00 million value, up from 5,255 last quarter. Pioneer Natural Resources now has $33.24 billion valuation. The stock decreased 0.27% or $0.52 during the last trading session, reaching $194.95. About 1.79 million shares traded or 12.60% up from the average. Pioneer Natural Resources Company (NYSE:PXD) has declined 4.79% since April 22, 2017 and is downtrending. It has underperformed by 16.34% the S&P500.

Investors sentiment decreased to 0.81 in 2017 Q4. Its down 0.82, from 1.63 in 2017Q3. It fall, as 21 investors sold Accelerate Diagnostics, Inc. shares while 32 reduced holdings. 15 funds opened positions while 28 raised stakes. 19.90 million shares or 6.66% less from 21.32 million shares in 2017Q3 were reported. Kornitzer Cap Management Ks stated it has 439,504 shares or 0.2% of all its holdings. Metropolitan Life Insurance Com Ny owns 0% invested in Accelerate Diagnostics, Inc. (NASDAQ:AXDX) for 8,727 shares. State Street Corporation invested 0% in Accelerate Diagnostics, Inc. (NASDAQ:AXDX). 26,272 are held by Bnp Paribas Arbitrage Sa. Raymond James And invested 0% in Accelerate Diagnostics, Inc. (NASDAQ:AXDX). Atlantic Gru Ltd Company accumulated 46,660 shares or 0.01% of the stock. Eaton Vance Mgmt has invested 0.01% in Accelerate Diagnostics, Inc. (NASDAQ:AXDX). Fmr Ltd Liability Com, a Massachusetts-based fund reported 242,525 shares. Obermeyer Wood Invest Counsel Lllp has 214,427 shares. Moreover, D E Shaw & Company Inc has 0% invested in Accelerate Diagnostics, Inc. (NASDAQ:AXDX) for 31,426 shares. Trellus Management Ltd Co reported 8,678 shares. 5,000 were accumulated by Cls Investments. Artal Group holds 0.2% or 500,000 shares in its portfolio. Miura Mngmt Ltd reported 2.28% in Accelerate Diagnostics, Inc. (NASDAQ:AXDX). First Republic Mgmt holds 0.11% or 608,600 shares.

Since February 20, 2018, it had 5 insider buys, and 0 sales for $1.50 million activity. 20,000 shares valued at $499,000 were bought by SCHULER JACK W on Tuesday, February 20.

Among 4 analysts covering Accelerate Diagnostics (NASDAQ:AXDX), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Accelerate Diagnostics had 9 analyst reports since August 25, 2015 according to SRatingsIntel. The stock of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) earned “Overweight” rating by Piper Jaffray on Wednesday, December 16. BTIG Research downgraded the shares of AXDX in report on Wednesday, December 13 to “Neutral” rating. The stock has “Neutral” rating by BTIG Research on Tuesday, August 25. The stock of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) earned “Outperform” rating by William Blair on Friday, January 8. JP Morgan maintained Accelerate Diagnostics, Inc. (NASDAQ:AXDX) on Tuesday, August 9 with “Overweight” rating. BTIG Research reinitiated the shares of AXDX in report on Wednesday, July 12 with “Buy” rating. The rating was maintained by Piper Jaffray with “Buy” on Thursday, August 3. The stock of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) earned “Buy” rating by Piper Jaffray on Sunday, September 17. JP Morgan initiated it with “Overweight” rating and $17 target in Thursday, March 24 report.

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States. The company has market cap of $1.37 billion. It offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms, as well as yeast. It currently has negative earnings. The firm was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012.

Investors sentiment decreased to 0.87 in 2017 Q4. Its down 0.16, from 1.03 in 2017Q3. It dropped, as 66 investors sold PXD shares while 230 reduced holdings. 89 funds opened positions while 168 raised stakes. 148.22 million shares or 2.39% less from 151.85 million shares in 2017Q3 were reported. First Quadrant LP Ca reported 0% of its portfolio in Pioneer Natural Resources Company (NYSE:PXD). Aristotle Lc holds 1.67% in Pioneer Natural Resources Company (NYSE:PXD) or 1.39 million shares. Fdx reported 0.04% in Pioneer Natural Resources Company (NYSE:PXD). Utd Capital Fin Advisers Lc reported 0.06% of its portfolio in Pioneer Natural Resources Company (NYSE:PXD). Jacobs And Ca accumulated 14,955 shares. The Washington-based Perkins Coie Tru has invested 0% in Pioneer Natural Resources Company (NYSE:PXD). Toronto Dominion Retail Bank reported 76,383 shares stake. Amarillo Financial Bank accumulated 2,478 shares or 0.14% of the stock. Texas Permanent School Fund invested in 46,455 shares or 0.1% of the stock. Susquehanna International Gp Llp owns 281,187 shares. Transamerica Fincl Inc has 0% invested in Pioneer Natural Resources Company (NYSE:PXD). Veritable LP holds 0.01% or 4,174 shares in its portfolio. Castleark Mgmt invested 0.89% in Pioneer Natural Resources Company (NYSE:PXD). Hartford Invest Mngmt Company invested 0.11% of its portfolio in Pioneer Natural Resources Company (NYSE:PXD). Baystate Wealth Management Limited Liability Corp owns 20 shares.

Since December 11, 2017, it had 0 buys, and 10 selling transactions for $3.90 million activity. Hopkins Frank E sold 2,000 shares worth $320,000. Another trade for 1,150 shares valued at $207,196 was made by KLEINMAN MARK H on Monday, February 26. The insider Fairbrook Teresa A sold $384,120. Shares for $31,870 were sold by Grillot Larry R.. The insider SHEFFIELD SCOTT D sold 2,000 shares worth $360,000. Montemayor Margaret had sold 1,410 shares worth $252,855 on Tuesday, February 27. 1,000 Pioneer Natural Resources Company (NYSE:PXD) shares with value of $159,505 were sold by DOVE TIMOTHY L.

L & S Advisors Inc decreased Alibaba Group Holding Ltd (NYSE:BABA) stake by 9,356 shares to 5,882 valued at $1.01M in 2017Q4. It also reduced Ld Abt Sht Durn (LLDYX) stake by 775,181 shares and now owns 2.22M shares. Union Pacific Corp. (NYSE:UNP) was reduced too.

Among 42 analysts covering Pioneer Natural Resources (NYSE:PXD), 37 have Buy rating, 1 Sell and 4 Hold. Therefore 88% are positive. Pioneer Natural Resources had 164 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Tuesday, April 5 by Drexel Hamilton. The firm has “Buy” rating given on Thursday, April 12 by Goldman Sachs. BMO Capital Markets maintained the shares of PXD in report on Wednesday, June 21 with “Buy” rating. The stock has “Hold” rating by Societe Generale on Wednesday, January 11. Mizuho maintained Pioneer Natural Resources Company (NYSE:PXD) rating on Tuesday, November 21. Mizuho has “Buy” rating and $190.0 target. The stock has “Buy” rating by Williams Capital Group on Monday, August 29. The firm has “Equalweight” rating given on Thursday, July 14 by Barclays Capital. JP Morgan initiated it with “Overweight” rating and $167 target in Wednesday, December 9 report. As per Tuesday, January 12, the company rating was maintained by Wunderlich. The company was maintained on Wednesday, August 5 by UBS.

By1 Michael Collier